Why (Almost) All of Us Cheat and Steal

Behavioral economist Dan Ariely talks about why everyone's willing to cheat a little, why you'll steal a staple from work but not petty cash and whether punishments for cheating actually work

Behavioral economist Dan Ariely, who teaches at Duke University, is known as one of the most original designers of experiments in social science. Not surprisingly, the best-selling authors creativity is evident throughout his latest book, The (Honest) Truth About Dishonesty. A lively tour through the impulses that cause many of us to cheat, the book offers especially keen insights into the ways in which we cut corners while still thinking of ourselves as moral people. Here, in Arielys own words, are seven lessons you didnt learn in school about dishonesty. (Interview edited and condensed by Gary Belsky.)

1. Most of us are 98-percenters.

A student told me a story about a locksmith he met when he locked himself out of the house. This student was amazed at how easily the locksmith picked his lock, but the locksmith explained that locks were really there to keep honest people from stealing. His view was that 1% of people would never steal, another 1% would always try to steal, and the rest of us are honest as long as were not easily tempted. Locks remove temptation for most people. And thats good, because in our research over many years, weve found that everybody has the capacity to be dishonest and almost everybody is at some point or another.

2. Well happily cheat until it hurts.

The Simple Model of Rational Crime suggests that the greater the reward, the greater the likelihood that people will cheat. But weve found that for most of us, the biggest driver of dishonesty is the ability to rationalize our actions so that we dont lose the sense of ourselves as good people. In one of our matrix experiments [a puzzle-solving exercise Ariely uses in his work to measure dishonesty], the level of cheating didnt change as the reward for cheating rose. In fact, the highest payout resulted in a little less cheating, probably because the amount of money got to be big enough that people couldnt rationalize their cheating as harmless. Most people are able to cheat a little because they can maintain the sense of themselves as basically honest people. They wont commit major fraud on their tax returns or insurance claims or expense reports, but theyll cut corners or exaggerate here or there because they dont feel that bad about it.

(MORE: What Matters More to Voters, Gas Prices or Jobs?)

3. Its no wonder people steal from work.

In one matrix experiment, we added a condition where some participants were paid in tokens, which they knew they could quickly exchange for real money. But just having that one step of separation resulted in a significant increase in cheating. Another time, we surveyed golfers and asked which act of moving a ball illegally would make other golfers most uncomfortable: using a club, their foot or their hand. More than twice as many said it would be less of a problem for other golfers, of course to use their club than to pick the ball up. Our willingness to cheat increases as we gain psychological distance from the action. So as we gain distance from money, it becomes easier to see ourselves as doing something other than stealing. Thats why many of us have no problem taking pencils or a stapler home from work when wed never take the equivalent amount of money from petty cash. And thats why Im a little concerned about the direction were taking toward becoming a cashless society. Virtual payments are a great convenience, but our research suggests we should worry that the farther people get from using actual money, the easier it becomes to steal.

4. Beware the altruistic crook.

Original post:
Why (Almost) All of Us Cheat and Steal

Clemson biz dean preps for Presbyterian's top post

Claude Lilly

CLEMSON Claude Lilly says his next four weeks at Clemson University will be just about the toughest time he's spent there.

The dean of the College of Business and Behavioral Science was elected unanimously last week to become Presbyterian College's 17th president.

He leaves Clemson next month.

"It's a bittersweet thing," said Lilly. "I have thoroughly enjoyed my job. It's been fantastic. But this was an opportunity I felt I should take. I can truly say I will miss Clemson."

Lilly has presided over a period of steady growth at the college, Clemson's largest, that has included moving its master's degree programs to downtown Greenville and launching an innovative program in entrepreneurial leadership.

He has served since 2007 as one of five deans who oversee the five colleges at Clemson. With new deans and an interim dean heading up three other colleges at the school, he was also second highest in seniority next to Larry Allen, dean of the College of Health, Education and Human Development for 11 years.

Lilly, an Atlanta native, was trained in finance and insurance at Georgia State University. He said college president is a role he had never envisioned early in his career. That career included 25 years spent as a finance and risk management professor at Florida State, Southern Cal and Texas Tech before becoming dean of the UNC Charlotte business school in 1998.

Still, reached by phone Monday, Lilly said the move to one of South Carolina's top private liberal arts schools makes sense.

An active member of Fort Hill Presbyterian in Clemson, Lilly also recently completed a four-year appointment to the church's national board of pensions.

The rest is here:
Clemson biz dean preps for Presbyterian's top post

Stacey Nemour: The Tao of Love, Sex and Anti-Aging: Part 9

Many of us tell ourselves that we will allow ourselves to be happy when:

A. I have X amount of dollars in the bank. B. I meet my true love/soulmate or when my partner finally wakes up and loves me the way he/she ought to. C. When I get a better job. D. When I lose weight.

The list can go on and on.

By focusing only on what we feel is lacking or what we need for our future, we put our present lives on hold or cause more delays because we are not connected to the present. The present is the future; as you read this sentence it is already one second later.

This powerful insight came to me during meditation, and it has created a huge shift in my reality. Each moment is an experience of success, so placing ourselves in the intentional knowing and understanding that we are living in the moment of success creates a continual chain of a successful life.

Doing this places us in a vibrational cycle that causes continuous experience to be a constant reflection of a life of perfection. Instead of meditating we can live the perfection by realizing the journey is the moment of perfection.

Nothing needs to happen in order for me to feel successful; I am successful right now. Nothing needs to happen in order for me to feel loved; I am loved right now. Nothing needs to happen in order to feel valid; I am valid right now.

To support a positive shift within and create harmonious relationships in personal and professional affairs:

1. Find the peaceful place inside now by not placing happiness outside yourself, which is reacting to external things. Freedom comes from creating your own reality independent of what others think or are doing.

2. Drop out of all high-drama situations. Just don't participate anymore.

More:
Stacey Nemour: The Tao of Love, Sex and Anti-Aging: Part 9

Anatomy of a Drug Manufacturing Plant (Last in a Three-Part Series Examining the Financial Impact of New Plant …

SUGAR LAND, TX--(Marketwire -06/18/12)- Reported by Annette Kreuger for Industrial Information Resources Sugar Land, Texas) -- Once construction has wrapped up and the validation process for a new pharmaceutical or biotech (pharma-bio) plant is complete, it is time to begin production. Not only does an operational plant manufacture drug products that improve the public's physical health, but it also sets off a ripple effect that is beneficial to the financial well being of the host community, county and state.

In the past 12-month period (6/2011-6/2012), 83 new Pharmaceutical & Biotech Industry plants began operations in North America. Industrial Info is tracking 185 additional new-build (or lease and equip) projects in various stages of planning, engineering or construction.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showAbstract.jsp?newsitemID=224180&refer=mw, or browse other breaking industrial news stories at http://www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the http://www.industrialinfo.com "Contact Us" page.

Continued here:
Anatomy of a Drug Manufacturing Plant (Last in a Three-Part Series Examining the Financial Impact of New Plant ...

Names and Faces

Today's most viewed articles Donatello receives AMA fellowship

KITTERY, Maine Dr. Jeff Donatello recently received a fellowship in Integrative Cancer Therapies from the American Academy of Anti-Aging Medicine.

The fellowship is sponsored by the American Medical Association through the South Florida School of Medicine. Donatello is now among a select group of 300 doctors and health care professionals who utilize proven therapies beyond chemotherapy and radiation to help people with cancer to regain and maintain their health.

Donatello's office is at 76 Route 1 Bypass in Kittery. For information, visit donatellobbt.com. For appointments, call (207) 438-9339.

PORTSMOUTH Piscataqua Savings Bank has announced the addition of three new members to its board of corporators.

The corporators represent individuals from the community asked to serve in an oversight capacity for the bank. The new members are: Philip L. Pettis, partner with the law firm of Boynton, Waldron, Doleac, Woodman and Scott in Portsmouth; Gregory C. Johnson, CFA, principal with Prime, Bucholtz and Associates, with offices in Portsmouth, Boston and Atlanta, Ga.; and Richard G. Kaiser, vice president/senior trust officer at Piscataqua Savings Bank.

The corporators annually elect the board of trustees and ensure the bank operates in the best interest of its customers and the community. At its recent annual meeting, corporators elected the following individuals to the board of trustees: Michael J. Asselin, Kenneth R. Clark, Jay S. Gibson, Charles A. Griffin, Ann H. Peters, Barbara Shea-Smucker, Vincent Taccetta III and Richard M. Wallis.

For information, visit http://www.piscataqua.com.

PORTSMOUTH Chambers and Partners, a London-based research organization, bestowed top rankings on Pierce Atwood LLP and its lawyers as part of law firm rankings that the research group released recently.

Pierce Atwood has a total of 40 lawyers recognized in the 2012 guide, Chambers USA: America's Leading Lawyers for Business. The firm's New Hampshire office in Portsmouth has two honorees named in the guide: Scott E. Pueschel, P.C., in the corporate/commercial area and Denis O. Robinson in the real estate area.

See the original post here:
Names and Faces

Fiberglass fibers cause lung diseases and cancer

By Paul Fassa

The case against asbestos in building materials was finalized after decades of research traced several severe lung cancer incidents to asbestos poisoning. Now fiberglass, the replacement for asbestos, is under similar scrutiny for the same reasons.

Independent researchers at Cornell University discovered that sick building syndrome (SBS), which causes many occupants to suffer similar health issues, occurred mostly in recently built airtight structures without adequate internal air cleaning systems. They ran out of research funds and couldn't continue.

A couple of decades ago, the National Institute for Occupational Safety and Health (NIOSH), a medical wing of the Department of Labor, made an alarming discovery regarding man made mineral fibers (fiberglass). They determined that the fibers created DNA damage, which leads to chronic illness and is carcinogenic.

An anti-regulatory Congress that encouraged the rapid rise of biotech industries, such as Monsanto, threatened to abolish NIOSH around that time. Meanwhile, the large suppliers of fiberglass insulation claim they've done their own research. Read more…

Cardiofy Heart Care Supplement

Source:
http://anti-aging-for-today.blogspot.com/feeds/posts/default?alt=rss

Global Telemedicine

Global TelemedicineTelemedicine has truly become a global industry. According to a report by BCC Research, the global telemedicine market reached $11.6 billion in 2011, and is expected to triple to $27.3 billion by 2016. In the U.S., the passage of new health insurance laws has sparked an increased focus on the use of telemedicine as a tool to reduce healthcare costs and streamline patient care. Telemedicine technologies can help healthcare providers meet the expected increase in demand for medical care without causing unnecessary delays in treatment or requiring cutbacks in other areas. With the use of telecare devices, software and services, physicians can diagnose and treat patients quickly and efficiently – from anywhere in the world.

The use of telemedicine technology, which is steadily growing in popularity in the U.S., has far-reaching applications worldwide. Telecare equipment, such as examination camerasremote monitoring devicesdigital scopes, and mobile telemedicine carts, allow patients in remote locations greater access to quality healthcare. By bringing the physician to the patient, telemedicine is truly transforming the way we think about traditional patient care. It is no longer necessary for rural patients, who often have limited resources, to travel great distances in order to receive quality medical care.

GlobalMed is poised to help medical care providers worldwide improve patient care with innovative telemedicine products, software and services. Whether you are just getting started with telemedicine, upgrading your existing technology or simply want more information about the products and services we offer, contact GlobalMed today to learn how we can help you. No matter where you are located in the world, we have a telemedicine representative near you.

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Ventana takes Digital Pathology to a new level with the new VENTANA iScan HT Scanner

TUCSON, Ariz., June 13, 2012 /PRNewswire via COMTEX/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces commercial availability of the VENTANA iScan HT slide scanner(1) in North America to be followed by Europe, the Middle East and Africa in July, 2012.

"The launch of the VENTANA iScan HT scanner is a significant milestone for the pathology industry. Digital pathology can increase diagnostic confidence, reduce subjectivity and ultimately improve patient care with consistent and reproducible results," says Mara G. Aspinall, President of Ventana Medical Systems, Inc. "This newest instrument exemplifies the latest advancements in digital technology that I believe will continue to transform the industry."

The VENTANA iScan HT slide scanner is the most powerful high-throughput brightfield scanner in the anatomic pathology market today, enabling pathologists and lab managers to optimize their digital pathology workflow with efficiency, convenience, speed, throughput and reliability for unprecedented results.

"I have put the VENTANA iScan HT through its paces in a thorough evaluation and find the instrument produces crisp, sharp digital images at both 20X and 40X. The intuitive user interface and consistently accurate detection of regions of interest provide a practical whole slide scanner for walk-away scanning in high volume environments," says Dr. John W. Bishop M.D., Sacramento, California.

Incorporating cutting-edge optical focus and slide handling technologies, the VENTANA iScan HT features include:

Unprecedented throughput: the new system holds up to 360 slides and scans up to 80 slides per hour

Superior quality images at 20X and 40X (580 and 1160 times actual magnification respectively)

Intuitive, efficient and flexible workflow management, enabling a lab manager to load and unload slides while the scanner is in active operation

"Pathology labs clearly have a need for a high throughput scanner. They work with hundreds, sometimes thousands, of glass slides a day," says Steve Burnell, Ph.D., Ventana Digital Pathology and Workflow Lifecycle Leader. "The growing VENTANA portfolio of integrated digital solutions including slide scanners, CE-IVD and FDA-cleared algorithms and VIRTUOSO image management and workflow software, underscores our commitment to providing the most innovative and advanced digital pathology solutions available globally."

The VENTANA iScan HT slide scanner is ideal for high throughput, high volume applications and complements the VENTANA complete suite of digital pathology solutions which also includes the iScan Coreo Au slide scanner, VIRTUOSO image and workflow management software, and a portfolio of RUO, CE-IVD and FDA-cleared 510(k) image analysis algorithms. The iScan Coreo Au slide scanner best supports low to mid-volume pathology labs and specific applications such as frozen sections. Both the VENTANA iScan HT and the iScan Coreo Au slide scanners are integrated with VIRTUOSO for complete workflow management software functionality from image acquisition through reporting.

The VENTANA iScan HT instrument was showcased at CAP 2011 and USCAP 2012. For more information, visit http://www.ventanadigitalpathology.com

(1) The VENTANA iScan HT slide scanner is for research use only in the US and is not for use in diagnostic procedures.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") (six:RO)(six:ROG)(otcqx:RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving Personalized Healthcare through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit http://www.ventana.com to learn more.

via MarketWatch

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Experienced Researcher Wanted for Image Analysis Application and Development–OncoMark Limited

We are looking for an experienced researcher to join OncoMark Limited (http://www.oncomark.com). Our offices are based at NovaUCD, which is a Technology Transfer and Innovation Centre at University College Dublin, Ireland (http://www.ucd.ie/nova). OncoMark is currently involved in an EU funded project entitled ‘Fast-Tracking Pathology via Automated Image Analysis and High-Performance Computing: Application to Prostate Cancer Diagnostics’ or FAST-PATH. This project is a Marie-Curie Industry-Academia Pathways and Partnership (IAPP) project, and involves 5 other partners around Europe.

Description

The researcher recruited to OncoMark will perform aspects of this project and will be responsible for developing and applying automated image analysis approaches for quantitation of prognostic biomarkers in prostate cancer. The researcher be involved in tailoring current proprietary algorithms for this specific project, and be a key driver in the commercial development of this software. The fellow will also be responsible for scanning of glass slides to create digital slides and performing automated image analysis. FAST-PATH is centred on taking advantage of the convergence between image informatics, high performance computing and tissue diagnostics, which is central to the emergent arena of digital pathology. Our consortium brings a range of advanced digital pathology expertise and approaches from both academic and industrial sectors to address some of the key issues in prostate cancer diagnostics.

Nr of positions available : 1

Research Fields

Biological sciences - Biology

Career Stage

Experienced researcher or 4-10 yrs (Post-Doc) 

Research Profile

Recognised Researcher (R2) 

Comment/web site for additional job details

Minimum Requirements:
- BSc in biological discipline or computer science
Jobs - EURAXESS - European Commission Page 1 of 5
http://ec.europa.eu/euraxess/index.cfm/jobs/jobDetails/33763943 21/03/2012
- MSc or PhD
- >4 years full-time research experience (including time spent doing post-graduate degree)
- Proven experience of image analysis algorithm development and computer programming (knowledge of C++ a requirement)
Desired:
- Knowledge of histology or tissue structure an advantage
- Knowledge of histological techniques (immunohistochemistry, tissue microarrays etc.)
- Ability to multi-task and work on different projects simultaneously
- Highly effective verbal and written communications skills
- Self-motivated and driven
- Experience working as part of a team
- Fast learner that requires minimal supervision
- Willingness to travel abroad to interact with collaborators and partners
Eligibility:
For recruitment under the Marie Curie IAPP, there are several rules regarding mobility:
• Researchers must not have resided or carried out their main activity in Ireland for more than 12 months in the last 3 years.
Contract:
- 1 year in OncoMark, Dublin, Ireland
Possible start date: May/June 2012
Salary: Salary subject to experience
Contact: To apply for this position please send a comprehensive CV and Cover Letter to jobs@oncomark.com.

Courtesy of The European Commission

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

An internist, surgeon and pathologist go duck hunting

This is an old joke but a recent experience with a surgeon taking out a long segment of bowel worried about a tumor without mentioning a site for the tumor or a solid reason why he thought there was a tumor reminded me of how true this can sometimes can be.

An internist, a surgeon and a pathologist decided that they were working too hard and that they should go duck hunting together.

A couple of mornings later found them sitting in a duck blind waiting for the birds. Pretty soon a bird appeared on the horizon.

The internist watched it carefully as it came over and said, "Gentlemen, observe the colorful plumage, the quacking call and the web feet trailing behind."

As the bird disappeared out of range, he said, "Based on my observation, I would venture that we have seen a duck, but further tests may be necessary before we decide on a course of action."

The surgeon was furious.  He told the internist, "It looked like a duck, it quacked like a duck, it was probably a duck."

The other doctors looked blankly at him, but there was a slight sneer from the surgeon.

It wasn't long until another bird appeared. They waited until it came closer and then the surgeon leaped to his feet with his gun. He started shooting wildy.

Feathers and pieces of feet, blood and guts and bill exploded overhead.

A sorry looking carcass fell to the ground.  

The surgeon turned to the pathologist and said "Go over there and tell me if that is a duck."

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

“By the year 2015, half of all medical images will be in the cloud”

Dell to Host Agfa Medical Imaging Database in the Cloud

Dell's cloud infrastructure will host Agfa's imaging archive to allow doctors to incorporate images into electronic health records.

Dell has announced it will host Agfa Healthcare's medical imaging archive in the cloud.

The cloud will provide the storage capacity and processing power as doctors look for ways to make medical images compatible with electronic health records (EHRs).

Cloud computing will be an essential factor in this effort, especially when IT budgets are tight, according to Dr. Jamie Coffin, vice president and general manager of Dell Healthcare and Life Sciences.

"The world is moving to a patient-centric view of the [EHR]," Coffin told eWEEK. "You have to start to think about digital radiology, pathology, genomics and figure out how to store this in a format where you take and use it wherever your clinician is."

Agfa's medical imaging archive, called Imaging Clinical Information System (ICIS), is a central repository that allows doctors to capture, store and exchange medical images.

Using ICIS in Dell's cloud, clinicians can capture a medical image and related metadata and "marry" it with the patient demographics in an EHR, Lenny Reznik, director of enterprise imaging and information solutions for Agfa HealthCare, told eWEEK. "Their clinical information system allows you to image-enable all of the data that they have in their [picture archiving and communications systems, or PACS] into the [EHR]," said Coffin. "The idea is that they store it in the cloud, and customers can access it from wherever they are and whatever platform they're on."

Dell and Agfa announced their partnership on June 7.

ICIS incorporates the Impax Data Center, which unifies patient records across regions, hospital facilities and departments. As a vendor-neutral system, ICIS can store images from various PACS.

The Agfa platform also includes the Xero Technology Viewer, a tool that allows doctors to stream the images from any Web-enabled device. The image viewer lets doctors embed images directly into an EHR.

Agfa customers will be able to access images either in Agfa's ICIS or Dell's Cloud Clinical Archive, said Coffin.

Dell announced a similar agreement with Siemens in February in which the two companies would collaborate on a vendor-neutral image archive in the cloud.

In addition, Dell will offer its Cloud Clinical Recovery platform to Agfa customers to provide disaster protection. Medical facilities using Agfa's imaging archive will be able to access additional analytics and data services in the future, said Coffin.

Hospitals with 300 to 400 beds that can't afford a data center infrastructure or the personnel to operate it will be able to manage their images and data in the cloud, said Coffin.

"By the year 2015, half of all medical images will be in the cloud," Reznik predicted.

By allowing ICIS to manage the archiving of radiology images, doctors are free to concentrate on treating patients, according to Agfa. Storing images in the cloud allows providers to track patients over time and maintain longitudinal medical imaging record access, Michael Green, Agfa HealthCare's president and CEO of Americas region, said in a statement.

Storing the medical images in the cloud will allow doctors' offices or medical centers to manage data-intensive images when they lack physical space to store their own servers.

"A single pathology slide can be like 6GB of data because it's a high-resolution image," Coffin noted. "It really brings an ROI to the customers they've never been able to get before [from] on-site image management."

In addition, archiving medical images in the cloud allows health care providers to meet the Stage 2 requirements on meaningful use of EHRs, according to Dell. Medical image viewing is an optional menu measure for achieving Stage 2 compliance.

As health information exchanges (HIEs) continue to connect data from diverse EHR platforms, the cloud will be an important foundation as data elements such as imaging, pathology and genomics are incorporated into the exchanges, Coffin suggested.

 

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

"X-ray Visions: Drawings and Prints from an Artist Residency at the NYU School of Medicine," Works by Laura Ferguson, Through August 13

On through August 13th at MSB Gallery at the NYU Health Sciences Libraries:

X-ray Visions: Drawings and Prints from an Artist Residency at the NYU School of Medicine
MSB Gallery, June 11 - August 13, 2012

What if we could look into the body’s inner space with a kind of enhanced x-ray vision, without the need for dissection or medical imaging – perhaps lit by candlelight, with an eye to the beauty within? As an artist at NYU’s School of Medicine I’ve worked to create this kind of personal vision, making drawings in the Anatomy Lab and from 3D radiology images of my own body.

Art looks beneath the surface of life, and for me the place to look has always been the body. A curving spine – asymmetry at my core – means that for me, walking, moving and even breathing require conscious effort, an engagement with the workings of my bones and muscles, nerves, and senses. Drawing myself lets me work from the inside out, to visually convey the feeling of inhabiting this particular, individual body, and the many ways that personal identity and even consciousness are rooted in physical experience.

I see my work as following in the Renaissance tradition of Leonardo da Vinci and his great anatomy drawings, informed by the new ways of seeing made possible by contemporary medical imaging technologies. As a patient with a lifetime of x-rays, I was always fascinated by these mysterious, shadowy pictures – but felt disconnected from a part of me that seemed to belong more to my doctors than to me. As an artist I’ve been able to reclaim this hidden territory for myself, and hope my work can bring viewers to feel a deeper sense of connection with their own unique inner spaces.

Learn more about the floating colors process.

You can find out more by clicking here.

Source:
http://morbidanatomy.blogspot.com/feeds/posts/default?alt=rss

A Few More Slots Left: "Drawing from the Bestiary: Animal Anatomy of Real and Imagined Creatures," Class with Artist Saul Chernick, Observatory, June 25-July 16

We still have just a few more slots available for the upcoming class "Drawing from the Bestiary: Animal Anatomy of Real and Imagined Creatures" with one of our favorite artists, Saul Chernick. This class will teach students--via illustrated lectures and in-class projects including paper puppets and the creation of bestiary pages--"to use observational and imaginative drawing skills in tandem to capture the essential qualities of their subject" and "learn to draw animals (real, mythic, and otherwise) with greater skill and sensitivity."

You can see some of Chernick's wonderful artworks above; you can see more of them by clicking here. The class will take place on 4 consectutive Mondays, from June 25 to July 16th. The full class description follows. Also, please note that the class size is limited to 15, so if you are interested, please RSVP as soon as possible to morbidanatomy [at] gmail.com.

Drawing from the Bestiary: Animal Anatomy of Real and Imagined Creatures with Saul Chernick
A 4-part class with Artist Saul Chernick, M.F.A., Rutgers University
Dates: Mondays June 25, July 2, July 9 and July 16th (4 consecutive Mondays)
Time: 6:30-9:00 PM
Class Fee: $120
***Class size limited to 15; Must RSVP to morbidanatomy [at] gmail.com
This class is part of The Morbid Anatomy Art Academy

Contemporary artist and arts educator Saul Chernickis renowned for gorgeous artworks featuring convincingly corporeal depictions of imaginary or mythical creatures rendered in the style of Medieval and early Renaissance woodcuts from Northern Europe. Observatory is very pleased to announce a new workshop developed by Saul Chernick specially for the Morbid Anatomy Art Academy. In this class, Chernick will teach students--via illustrated lectures and in-class projects including paper puppets and bestiary pages--"to use observational and imaginative drawing skills in tandem to capture the essential qualities of their subject" and "learn to draw animals (real, mythic, and otherwise) with greater skill and sensitivity."

Full class description follows; you can see more of Chernick's fantastic work by clicking here. Class size limited to 15; Please RSVP to morbidanatomy [at] gmail.com.

Course Description
Open to artists of all levels, the goal of this workshop is help participants learn to draw animals (real, mythic, and otherwise) with greater skill and sensitivity. Through exercises in drawing and paper puppetry, participants will gain a deeper understanding of the skeletal/muscular structures of most mammals, reptiles, and birds. Participants will also learn to use observational and imaginative drawing skills in tandem to capture the essential qualities of their subject and create works of convincing visual fiction!
What to expect

  • Participants will cull images from the web to create a dossier on the animal(s) that interest them
  • Participants will fashion movable paper puppets to understand how their chosen animal moves
  • Participants will draw studies of the skeletal and muscular structures of animals
  • Participants will use the medium of their choice to create a Bestiary page entry that depicts an animal situated in an environment

Materials
What to bring to the first class:

  • Choose 1-3 animals and gather pictures on the web. Be sure to get images of their skeletons in profile. Please print these as they may be hard to use on a phone screen.
  • 3-5 sheets of Bristol Board Paper 9" x 12" or larger
  • Pencils & erasers
  • Scissors
  • Xacto or utility knife
  • Glue

What to bring for subsequent classes:

  • White or tinted drawing paper 16" x 20" or 18" x 24"
  • Tracing paper (same size as drawing paper)
  • Mechanical and/or regular pencils (2h, hb, 2b, 4b)

Optional:

  • Markers, watercolors, gouache, ink, brushes, chalk/oil pastels, colored pencils, Caran D’Ache, collage papers, etc (we’ll discuss further in detail!)

Saul Chernick, M.F.A., Rutgers University, is a visual artist and educator. Chernick has exhibited internationally in galleries and museums including the Aldrich Museum of Contemporary Art, the Bronx Museum of Art, the Jewish Museum of Art, as well as Max Protetch and Meulensteen Galleries in New York City. He has taught art for the public school system, the 92nd Street Y, Cooper Union, Parson's School of Design, and the Museum of Modern Art. He is currently the Professional Development Coordinator for the Joan Mitchell Foundation where he coaches New York artists in teaching art to young people throughout city. His work can be seen at http://www.saulchernick.com.

All images are by Saul Chernick and include, top to bottom:

  1. Field Urchin, 2011, from a series of studies in which he attempted to impose the proportions of cherubs onto horses.
  2. Desktop 2013, 2010, Ink, Watercolor, & Opaque White on Paper
  3. Heavenly Touch , 2009, Ink, Watercolor, & Opaque White on Paper
  4. Guilty Pleasures, 2010, Ink, Watercolor, & Opaque White on Paper
  5. Ars Gratia Artis, 2010, Ink on Paper

You can found out more here. As mentioned above, class size is limited to 15, so if you are interested, please RSVP as soon as you are able to morbidanatomy [at] gmail.com.

Source:
http://morbidanatomy.blogspot.com/feeds/posts/default?alt=rss

The Art of Illusions: Pre-cinematic Entertainment in Mexico, Velaslavasay Panorama, Los Angeles, June 16th


If only I lived in Los Angeles....

This Saturday, at the fantastic Velaslavasay Panorama:

The Art of Illusions
Pre-cinematic Entertainment in Mexico
An Illustrated Lecture by José Antonio Rodríguez
Saturday, June 16th
8 o ’clock pm
Tickets $12 {$10 VPES Members}
Advance tickets are highly recommended and are available at
https://www.brownpapertickets.com/event/242705
_____________________

The Velaslavasay Panorama welcomes José Antonio Rodríguez, who will be here to present an illustrated lecture about pre-cinematic entertainment in Mexico.

Having conducted research on the subject for many years, José Antonio Rodríguez will talk about the multitudinous forms of optical magic, including the magic lantern, diorama, cosmorama, panorama and scientific spectacles which were once popular throughout Mexico and beyond. Professor Rodríguez will discuss the entertainments and forms of visual culture in the eighteenth century as they were experienced in Mexico, which inspired and made possible the proliferation of moving images. He will also address the archaeology of visual media which encouraged the later popularity of the Kinetoscope and the Cinematograph in nineteenth century Mexico. In essence, "The Art of Illusions" will present ideas about how our encounters with visual spectacles guide us in constructing our own vision of the world.

José Antonio Rodríguez is an Art History professor of at the Universidad Nacional Autónoma de México (UNAM) and the author of the landmark publication The Art of Illusions: Pre-cinematic Entertainment in Mexico published through the National Institute of Anthropology and History in Mexico. He is also the author of Edward Weston: The Look of Rupture; Bernice Kolko: Photographer; Ruth D. Lechuga: A Mexican Memory; and Agustin Jimenez: Memories of the Avant-Garde. He is also the editor of the magazine Alquimia, amongst other works. This will be Professor Rodríguez's first appearance in Los Angeles.
This presentation has been funded in part by The Department of Cultural affairs of the City of Los Angeles, The Andy Warhol Foundation for the Visual Arts and The Velaslavasay Panorama Enthusiast Society.

You can find out more by clicking here.

Source:
http://morbidanatomy.blogspot.com/feeds/posts/default?alt=rss

Should Physicians Invest in Facebook?

via Medscape

Physicians and other investors often kick themselves for not having grabbed the opportunity to invest early in Microsoft, Google, or other companies whose stock price skyrocketed. Many doctors think that Facebook shares present the same type of once-in-a-lifetime opportunity. Are they right?

The debacle of Facebook's initial public offering should make anyone leery of jumping into an IPO, if they weren't already skeptical about them.

But it begs the question of whether one should invest in the social networking site that has revolutionized how people communicate with each other.

The much-anticipated IPO, which offered 421 million shares at $38 and valued Facebook at more than $100 billion, was the subject of incredible hype beforehand and an emotional backlash afterwards as the price plummeted nearly 20% in the first few days of trading.

Analysts branded it a "broken IPO" and one compared the stock to a "falling knife" that no one wanted to grab.

MarketWatch commentator Chuck Jaffe scolded anyone who believed the hype by labeling the IPO "the stupid investment of the week," and said that the experience should teach investors once and for all that the letters IPO really stand for "it's probably overpriced."

Subsequent trading seemed to drive that point home as Facebook shares continued to dive, declining more than 30% from the IPO price of $38. The head of Morgan Stanley, which was the lead manager on the share sale, said investors were "naive" if they thought they would profit on the first day of trading.

Inspired by Other Tech Stock Winners

But optimists had visions of another Google dancing in their heads, which saw its share price double in the first few months of trading and quintuple within 2 years (though it has oscillated around $600 since then, with occasional bigger dips).

Apple, whose share price has risen steadily over the past 5 years, quintupling in value, probably ranks as the most successful big tech share. Apple, however, makes things that people buy -- iPhones, iPads, laptops, PCs -- and also makes a ton of money raking off part of the proceeds from content that gets sold to people using these devices.

Facebook, and Google for that matter, have more intangible assets -- hundreds of millions of Internet users who leave behind useful traces about what they're interested in buying.

Google, though, has proven that it knows how to deliver advertising messages to people who are interested in them, while Facebook has yet to figure out just how to insert commercials into the social networking experience.

General Motors drove home that point with the announcement just before Facebook's IPO that it was pulling its advertising from the site because it had seen no measurable return on that investment.

Facebook is nonetheless the 800-pound gorilla in a social networking phenomenon that has swept the globe. And while many still think it is just a passing fad, you'd have a hard time convincing anyone under 30 that such networking is not a permanent fixture in their lives.

Why You Should or Shouldn't Snap Up the Stock

For now, it seems likely that Facebook stock will be buffeted by high-frequency traders looking for quick profits in a volatile issue. More shares will be hitting the market in coming months as IPO lockups expire, so that it will be some time before a reliable price picture emerges. Some analysts see a chance of the stock going as low as $10, while others are tipping $44 in the short term.

Obviously nobody knows. Every investor has to make his or her own decision, and you will probably want to consult with your financial advisor in figuring it out for yourself. But answering the question of whether you should invest in Facebook makes for an interesting case study in which to review some tried-and-true rules on investing.

1. Don't invest in IPOs

Jaffe is right. Pricing IPOs has always involved balancing the desire of the sellers (the founders and investors who got the new company off the ground) for the highest possible price and the preference of the buyers (institutions and individuals) for the price that will allow the greatest chance for future gains. That balance has tilted decidedly in favor of the sellers in recent years, and many analysts are saying that Facebook's $38 IPO price was too high and will make it difficult for other tech companies to go public.

Although some institutional investors may feel it is necessary to get in on the ground floor with a stock that could become a must-own issue, there's very little reason for retail investors to feel that way.

There was a time when a stock that sold for $38 might never look back and you wouldn't have a chance to get it below $50 or $75. But that hasn't happened in a while, and your chances of getting lucky on one of those issues are not great.

In this case, you would have been better off waiting a day or two and picking up the stock for $31 -- if you think it's a good investment.

2. Invest in what you know

It would almost certainly be foolish to invest in Facebook unless you were an active user on the network or could talk to friends, children, or grandchildren who are. Facebook's main asset is its 900 million active users, so it's very important to have a feel for what they're thinking to understand the future of the company.

Rupert Murdoch's News Corp. missed the boat when it acquired MySpace, an early Facebook rival and the market leader at the time, for $580 million in 2005 only to sell it just 6 years later for $35 million after MySpace lost out to Facebook.

Analysts say that Facebook users -- the college generation that first embraced it a decade ago -- are already "aging" and that younger people today have numerous alternatives, such as Twitter, Pinterest, and Flickr, among others. Will members continue to use Facebook as faithfully as they have done, or will the switch from PCs to mobile phones as the main communication device favor some of these other formats?

Facebook has had some difficulty making the transition to smart phones, and the company's purchase of the photo-sharing service Instagram for $1 billion this spring was designed to help close that gap.

In a case like Facebook, your view of the company's future will depend a lot on what you think of Mark Zuckerberg, the young man who founded it and masterminded its rise as the premier social networking site. Can Zuckerberg continue to reinvent Facebook in a fast-moving tech environment in the way that Steve Jobs kept reinventing Apple? Reports out just this week say that Facebook is getting serious about developing its own smart phone and may spend another $1 billion buying the Norwegian developer of a versatile browser.

Other Important Considerations

3. Limit your exposure

Where does an investment in Facebook fit into your portfolio? Is it a purely speculative stock or do you see it as a key component of a 21st century portfolio? What is your timeframe? Do you want to see a strong gain and early exit or is this a buy-and-hold stock?

Because Facebook is not only a new company but basically a whole new industry -- social networking -- it is difficult to evaluate its performance so far or to make any forecasts. There is no track record or benchmark for this industry.

The phenomenon of social networking could vanish as quickly as it appeared, or Facebook could begin to look like a dinosaur as newer, nimbler rivals appear on the scene. For that reason, you have to be ready to lose your entire stake in Facebook or set a strict limit for selling if it reaches the price marking how much you're willing to lose. "Strict" means that you really sell at that price and don't fall into the retail investor's trap of holding out for the stock to come back.

If you go into the stock for a relatively quick gain, set a deadline depending on the timeframe for this investment. Is "quick" 1 year or 5 years? You could have sold Google after 2 years, for instance, and booked the same gains as if you had held it and sold now.

4. What is your opportunity cost?

If you invest in Facebook now, will it make more money for you than other investments would? Value investors look for stocks that are undervalued. A lot of people concluded that Facebook was overvalued when it plummeted in the first few days of trading, but some analysts felt that it was undervalued at the IPO price of $38 and really undervalued at $31.

Facebook has no track record, so it might be easier to identify other stocks as undervalued based on their performance. David Rolfe of the RiverPark/Wedgewood Fund suggested at the time of the Facebook IPO that investors would be better off putting their money into proven stocks such as Warren Buffett's Berkshire Hathaway and Apple, which seem to be undervalued now based on their past performance.

5. Know what you're looking for in an investment

Some retail investors are abandoning the stock market, which they see as a casino rigged in favor of the house. The Facebook IPO seems to be a poster child for everything that's wrong with Wall Street now -- institutional investors getting better information, technology favoring the big investors over small investors, greed overcoming fairness.

But the very size of the company and of the initial float of more than 400 million shares should make Facebook less volatile once the waves from the IPO finally subside. In other words, if Facebook has a future, buying shares is probably a good way to benefit from it, regardless of the IPO glitches.

Many investors would prefer to hit a home run with a great stock pick than play the small ball of eking out gains through a well-balanced mutual fund. But that can lead to a lot of attempts and failures. Are you in a position now in your career or your retirement planning that you can afford to take a big loss if it means you could potentially have a huge win? If so, maybe you will want to step up to the plate and take a swing.

via Medscape - Medscape Business of Medicine © 2012 WebMD, LLC

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Amber Parle not your typical UCDavis grad

Animal biology major Amber Parle, selected the student commencement speaker for the UC Davis College of Agricultural and Environmental Sciences' afternoon ceremony on Sunday, is not your usual graduate.

In 2011 Parle completed her first full marathon, only a year and two weeks after being hit by a car while walking in downtown Davis. And, beginning this fall, she will "follow her dream" by traveling the world for 10 years.

After being hit by a car, "I realized that life is too fragile to let dreams slip away, and so I decided that after college I would travel the world -- spending a year in each country for a total of ten years," she said.

Parle will speak at the 2 p.m. commencement in the Activities and Recreation Center Pavilion, where the College of Ag will confer degrees to students from 21 departments, including animal biology and entomology.

The other College of Ag commencement ceremony starts at 9 a.m. at the same site, and encompasses the other nine departments, including plant sciences and environmental horticulture and forestry.

Forensic entomologist Robert Kimsey serves as the master advisor of the animal biology program, which includes some 350 students. "Amber has a first-rate mind," he said, "and she led her study group."

Parle, born and reared in Southern California, is a 2008 graduate of Big Bear High School, Big Bear City, San Bernardino County. The valedictorian of her class, she was one of seven students, countywide, selected

Parle enrolled at UC Davis immediately after high school. During her time at UC Davis she explored several interests including painting, acting, drawing, photography, fitness, writing, and singing. She is currently working on her first novel and a collection of poems -- both of which she hopes to get published soon.

Parle will be leaving for South Korea in fall of 2012, where she has a yearlong contract to teach English.

After that "I will go wherever my heart takes me," she said.

Go here to see the original:
Amber Parle not your typical UCDavis grad

Miss Davis County crowned Miss Utah 2012

Kara Arnold, Miss Davis County, was crowned Miss Utah 2012 on Saturday night at the Capitol Theater in Salt Lake City.

Arnold, of Bountiful, is a biochemistry major at the University of Utah and was recently accepted into the universitys medical school. Along with the title she won Saturday, she will receive a $10,000 scholarship to help her toward her goal of becoming a physician. She received a preliminary award for academic excellence, which is sponsored by and decided upon by the Miss America organization.

During her reigning year, Arnold will travel the state promoting her chosen platform "Discover Your Potential Step Up with STEM," serving as an ambassador for the Childrens Miracle Network Hospitals. She will also be the official spokeswoman for the Child Protection Registry, which is dedicated to protecting Utah families from adult-oriented solicitations.

First runner-up was Miss Duchesne County, Brittani Reinhardt; second runner-up was Miss Pioneer Valley, Ciera Pekarcik; and third runner up was Miss Orem, Hannah Harkness. All will receive varying amounts of scholarship money.

Copyright 2012 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Read the original post:
Miss Davis County crowned Miss Utah 2012

Centenary College hosts tactical interview program

Centenary Colleges Institute for Law Enforcement & Emergency Services Education (ILEESE) held its fourth annual major in-service training event to educate the law enforcement community, on The Tactical Interview Program, on June 5 at Centenary College in the David and Carol Lackland Center. A total of 252 members of law enforcement were in attendance. The seminar was funded at no cost to participants through a grant from the United States Department of Justice.

Jerry Lewis, who is a consultant in the areas of behavioral science and statement analysis, led the seminar. Topics included a psychological analysis of the interview from the viewpoints of the investigator as well as the subject and how an investigator may determine truthfulness, deception and their relative value in an interview. The strategies are designed to enhance interviewing skills through the application of scientific principles and persuasive techniques.

Lewis specializes in the areas of law enforcement and education. He spent 25 years in the New Jersey State Police. During his tenure, he supervised the Violent Crime Analysis and Polygraph Unit. He currently maintains a relationship with law enforcement agencies throughout the United States as both a consultant and instructor in his areas of expertise. He possesses a Masters Degree in Education from Seton Hall University, holds an adjunct faculty position with Northwestern University and has been a guest lecturer at the Delaware State Police Homicide School, New Jersey Homicide Investigators Association Conference and the New Jersey Missing Persons School.

He has conducted interviews and analyzed statements in thousands of cases involving every type of criminal case. The techniques he developed over 30 years of experience are based on the science of the mind and result in confessions from 90 percent of guilty subjects, regardless of culture, upbringing, or intelligence. In 1988, he developed the five day New Jersey State Police Interviewing and Interrogation School. He has customized training for numerous federal, state, county and local law enforcement agencies such as U.S. Customs, IRS, Chicago Police Department, Delaware State Police, Anne Arundel County Maryland, Royal Canadian Mounted Police, Ontario Provincial Police, Magloclen, and regularly presents his four-day course at police academies through New Jersey.

This program will be extremely useful for these professionals, says Mark Noll, director of the Institute for Law Enforcement & Emergency Services Education at Centenary College. The seminar not only illustrated what to ask and what not to ask, it also outlined how one may analyze statements so as to determine truth and deceit.

Read the original post:
Centenary College hosts tactical interview program

Stemtech: Stem cell nutrition could eclipse antioxidant supplement market

The emerging field of stem cell nutrition has the potential to eclipse the massive antioxidant supplement business according to the boss of the Californian firm responsible for creating a completely new category in nutritional supplements.

Ray Carter Jr, CEO of Stemtech International, was speaking to NutraIngredients-USA after signing a multi-million dollar deal with Australian biotech firm Marinova to include its proprietary Fucoidan ingredients in Stemtechs new SE2 supplement.

The next generation of Stemtechs best-selling StemEnhance supplement, SE2 also includes a concentrate of blue-green algae Aphanizomenon flos-aquae (AFA), the herb Polygonum multiflorum and the fungus Cordyceps sinensis.

Adult stem cells, tissue maintenance and repair

SE2 helps increase the number of adult stem cells or master cells that are released into the bloodstream before migrating into tissues where they reproduce and become new healthy cells, effectively helping the body renew and repair itself, claimed Carter.

Stemtech products have already generated more than $200m in sales since 2005, he added: Stem cell nutrition addresses a brand new way to support health [and]has the potential to eclipse the massive antioxidant supplement business.

When consumers first heard the words stem cell, they were inundated with media reports about the controversy and promise of embryonic stem cell (ESC) research.

Fast forward to today, and they are beginning to learn that adult stem cells actually show much more clinical promise without the ethical and moral controversy surrounding ESCs.

The bodys natural renewal system

Adult stem cellshave been shown to be the bodys natural renewal system, he claimed.

View original post here:
Stemtech: Stem cell nutrition could eclipse antioxidant supplement market